However, the precise mechanism underlying the suppressive effect of SNORD113-3 on the expression of PKM2 and ACLY proteins, leading to the inhibition of glycolipid metabolism as well as proliferation in GBM cells, remains unclear. This evidence concerns the gene PKM and glioblastoma.